Related Experiment Video
Updated: Mar 30, 2026

Author Spotlight: Advanced Ex Vivo Model for Investigating Cancer-Adipose Microenvironment Interaction
Published on: January 26, 2024
miR-382 inhibits migration and invasion by targeting ROR1 through regulating EMT in ovarian cancer
Hong Tan1, Qingnan He2, Guanhui Gong3
1Department of Pathology, School of Basic Medical Science, Central South University, Changsha, Hunan 410013, P.R. China.
Abstract:
Increasing evidence suggests that microRNAs (miRNAs) play a critical role in tumorigenesis. Decreased expression of miR‑382 has been observed in various types of cancers. However, the biological function of miRNA-382 in ovarian cancer is still largely unknown. Here, we found miR‑382 was downregulated in human ovarian cancer tissues and cell lines. miR‑382 inhibited ovarian cancer cell proliferation, migration, invasion and the epithelial-mesenchymal transition (EMT). Furthermore, we identified receptor tyrosine kinase orphan receptor 1 (ROR1) as a target of miR‑382, and miR‑382 rescued the promotion effect of ROR1 on migration, invasion and EMT process in SKOV3 and COV434 cells. Collectively, these findings revealed that miR‑382 inhibits migration and invision by targeting ROR1 through regulating EMT in ovarian cancer, and might serve as a tumor suppressor in ovarian cancer.
Insights
MicroRNA-382 (miR-382) is downregulated in ovarian cancer, inhibiting cell proliferation and metastasis. It targets ROR1, suppressing migration and invasion by regulating epithelial-mesenchymal transition (EMT).
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- MicroRNAs (miRNAs) are crucial in cancer development.
- Reduced miR-382 expression is noted in several cancers.
- The role of miR-382 in ovarian cancer remains unclear.
Purpose of the Study:
- To investigate the function of miR-382 in ovarian cancer.
- To identify the molecular targets of miR-382 in this context.
Main Methods:
- Analysis of miR-382 expression in ovarian cancer tissues and cell lines.
- Assessment of miR-382's effects on ovarian cancer cell proliferation, migration, invasion, and epithelial-mesenchymal transition (EMT).
- Identification and validation of ROR1 as a direct target of miR-382.
Main Results:
- miR-382 expression was significantly downregulated in human ovarian cancer tissues and cell lines.
- Overexpression of miR-382 suppressed ovarian cancer cell proliferation, migration, invasion, and EMT.
- Receptor tyrosine kinase orphan receptor 1 (ROR1) was identified as a direct target of miR-382.
- miR-382 counteracted ROR1's pro-migratory, pro-invasive, and EMT-promoting effects.
Conclusions:
- miR-382 functions as a tumor suppressor in ovarian cancer.
- miR-382 inhibits ovarian cancer cell migration and invasion by targeting ROR1 and regulating EMT.
- miR-382 represents a potential therapeutic target for ovarian cancer.
Related Concept Videos
MicroRNAs
MicroRNAs
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Cancer Cell Migration through Invadopodia

